Insight Molecular Diagnostics (IMDX) Net Cash Flow Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 144.76% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 29.81% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 41.14% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 4.49% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 54.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.60% |
| Dec 31, 2025 | 11.65% |
| Sep 30, 2025 | 23.73% |
| Jun 30, 2025 | -31.56% |
| Mar 31, 2025 | 51.47% |
| Dec 31, 2024 | 38.94% |
| Sep 30, 2024 | -22.92% |
| Jun 30, 2024 | 31.93% |
| Mar 31, 2024 | -27.54% |
| Dec 31, 2023 | -11.38% |
| Sep 30, 2023 | 18.00% |
| Jun 30, 2023 | 194.00% |
| Mar 31, 2023 | -20.85% |
| Dec 31, 2022 | -64.33% |
| Sep 30, 2022 | 7.94% |
| Jun 30, 2022 | 108.92% |
| Mar 31, 2022 | -35.48% |
| Dec 31, 2021 | -40.53% |
| Sep 30, 2021 | -100.00% |
| Jun 30, 2021 | -74.92% |